Description:FIELD OF THE INVENTION

[0001] The present invention relates to a monitoring and management system for pharmaceutic industry that is capable of maintaining and regulating critical environmental parameters like air quality, temperature, and humidity across various areas of the pharmaceutical facility in view of ensuring compliance with industry standards and safeguarding product integrity.

BACKGROUND OF THE INVENTION

[0002] In the pharmaceutical industry, monitoring and management are critical to ensure product quality, safety, and regulatory compliance. The pharmaceutical sector operates in highly regulated environments where the slightest deviation from standard operating procedures lead to significant risks, including compromised drug quality, patient safety concerns, and legal penalties. Environmental factors such as temperature, humidity, air quality, and particulate contamination directly affect the integrity of pharmaceutical products especially in storage and manufacturing processes. Real-time monitoring methods are essential to track these conditions continuously and trigger alerts when thresholds are breached for ensuring immediate corrective actions. With increasing global demand for pharmaceuticals and the complexity of drug development, surrounding monitoring methods not only protect public health but also safeguard the company’s reputation and bottom line. Compliance with Good Manufacturing Practices (GMP) and other industry standards requires precise environmental control, making monitoring and management an indispensable part of the pharmaceutical industry’s infrastructure.

[0003] Traditional methods of surrounding monitoring and management in the pharmaceutical industry typically rely on manual checks and basic instrumentation such as thermometers, humidity gauges, and visual inspections. These methods involve periodic sampling or spot checks to monitor critical parameters like temperature, humidity, air quality, and cleanliness in manufacturing and storage areas. Operators often record data manually which is prone to human error and delays in response times. These methods while functional, lack real-time monitoring and fail to provide immediate alerts in case of deviations from set parameters. Traditional methods are labor-intensive, requiring frequent interventions, and result in inconsistencies due to human oversight. In addition, data collected manually or via basic instruments is often difficult to analyze in real time making this challenging to take corrective actions promptly. The lack of integration with technologies means that manual processes are also less efficient and more resource-draining. These limitations increase the risk of non-compliance with regulatory requirements, such as Good Manufacturing Practices (GMP), and compromise product quality or safety. While traditional methods significantly hinder operational efficiency and risk the ability to maintain high standards in pharmaceutical production environments.

[0004] US20010033233A1 discloses about an invention that has a device for product monitoring and management is applicable in or on a product and includes transmitter/receiver means wherein data relating to the product may be stored, wherein the data relating to the product may be written into and read from the transmitter/receiver means free of contact with the aid of external write-read means. The device moreover includes sensor means for monitoring a temporally variable condition parameter of the product and transmitting data corresponding to a currently prevailing condition to the transmitter/receiver means in dependence on a detected value of the temporally variable condition parameter. The data corresponding to the currently prevailing condition are written into the transmitter/receiver means in response to transmission from the sensor means. Furthermore, a method for product monitoring and management is disclosed.

[0005] WO2006052742A2 discloses about an invention that has an apparatus and method are provided for analyzing the release of active agent(s) from pharmaceutical and pharmaceutical-like products. The apparatus and method provide for more accurate simulation of the conditions in the GI tract including forces that are applied to the dosage form.

[0006] Conventionally, many methods are available for monitoring and managing surrounding area of the pharmaceutic industry. However, the cited invention lacks in providing means for monitoring environmental parameters such as air quality, temperature, and humidity in real-time. The cited methods do not have the capability to detect harmful elements and/or provide notifications in such scenarios which put the life of the people working in such industries at risk.

[0007] In order to overcome the aforementioned drawbacks, there exists a vital need in the art to develop a system that is capable of providing comprehensive monitoring and management of both environmental conditions and operational compliance within the pharmaceutical industry. The developed system should be capable of detecting and maintaining optimal environmental parameters in real-time for ensuring that safety guidelines are adhered to by employees and automating responses to potential safety violations, while also must offer proactive safety measures, such as the detection of hazardous gases and the projection of emergency protocols that result in a more efficient, safe, and compliant working environment.

OBJECTS OF THE INVENTION

[0008] The principal object of the present invention is to overcome the disadvantages of the prior art.

[0009] An object of the present invention is to develop a system that is capable of enabling efficient monitoring and management of environmental conditions in different areas of a pharmaceutical industry to ensure optimal production and storage conditions.

[0010] Another object of the present invention is to develop a system that is capable of facilitating real-time detection of employee adherence to safety and operational guidelines in view of ensuring compliance and minimizing risks.

[0011] Another object of the present invention is to develop a system that is capable of providing automated control of environmental parameters such as air quality, humidity, and temperature in pharmaceutical areas to maintain regulatory compliance and product quality.

[0012] Another object of the present invention is to develop a system that is capable of enhancing the safety and operational efficiency of the pharmaceutical environment by enabling automated responses to deviations in environmental conditions or employee behavior.

[0013] Another object of the present invention is to develop a system that is capable of ensuring quick detection and intervention in case of hazardous conditions, such as the release of toxic gases for improving workplace safety for employees.

[0014] Yet another object of the present invention is to develop a system that is capable of providing proactive maintenance and adjustment of environmental factors for maintaining optimal conditions.

[0015] The foregoing and other objects, features, and advantages of the present invention will become readily apparent upon further review of the following detailed description of the preferred embodiment as illustrated in the accompanying drawings.

SUMMARY OF THE INVENTION

[0016] The present invention relates to a comprehensive monitoring and management system for pharmaceutic industry to monitor employee behavior and adherence to safety protocols in real-time for issuing alerts when violations are detected, thereby promoting a safe and efficient working environment in pharmaceutic industry.

[0017] According to an embodiment of the present invention, a monitoring and management system for pharmaceutic industry, comprising multiple cuboidal bodies installed in various areas of the facility, each linked to a central computing unit via wireless communication. The system allows a user to input commands specifying the operation type in each area. A microcontroller processes these inputs and is connected to a database containing critical parameters like Air Quality Index (AQI), humidity, and temperature required for each operation. The database enables the microcontroller to monitor real-time environmental conditions through sensing module integrated into each cuboidal body, such as AQI, humidity, and temperature sensors. If any of these conditions deviate from the required settings, the microcontroller sends a signal to activate the HVAC system and air purifiers to restore the correct parameters. The system is equipped with an AI-based imaging unit and a telescopic rod to detect overhead objects and adjust the placement of the cuboidal bodies near the ceiling. The system also includes a gas sensor for detecting hazardous gas releases and activates a holographic projection unit to guide employees in emergency procedures. The microcontroller also issues alerts if this detects any employee disobeying safety guidelines. Power for the system's electronic components is supplied by a dedicated battery.

[0018] While the invention has been described and shown with particular reference to the preferred embodiment, it will be apparent that variations might be possible that would fall within the scope of the present invention.

BRIEF DESCRIPTION OF THE DRAWINGS

[0019] These and other features, aspects, and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying drawings where:
Figure 1 illustrates an isometric view of a monitoring and management system for pharmaceutic industry.

DETAILED DESCRIPTION OF THE INVENTION

[0020] The following description includes the preferred best mode of one embodiment of the present invention. It will be clear from this description of the invention that the invention is not limited to these illustrated embodiments but that the invention also includes a variety of modifications and embodiments thereto. Therefore, the present description should be seen as illustrative and not limiting. While the invention is susceptible to various modifications and alternative constructions, it should be understood, that there is no intention to limit the invention to the specific form disclosed, but, on the contrary, the invention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention as defined in the claims.

[0021] In any embodiment described herein, the open-ended terms "comprising," "comprises,” and the like (which are synonymous with "including," "having” and "characterized by") may be replaced by the respective partially closed phrases "consisting essentially of," consists essentially of," and the like or the respective closed phrases "consisting of," "consists of, the like.

[0022] As used herein, the singular forms “a,” “an,” and “the” designate both the singular and the plural, unless expressly stated to designate the singular only.

[0023] The present invention relates to a monitoring and management system for pharmaceutic industry to swiftly identify and address potential risks such as toxic gas releases in pharmaceutical industry and provide immediate corrective actions in view of ensuring both employee health and product safety.

[0024] Referring to Figure 1, an isometric view of a monitoring and management system for pharmaceutic industry is illustrated, comprising a plurality of cuboidal bodies 101, associated with the system, developed be installed at different areas of a pharmaceutical industry, an artificial intelligence-based imaging unit 102 mounted on each of the bodies 101, a telescopically operated rod 103 installed on each of the bodies 101 to extend, a motorized clamp 104 equipped with each of the rod 103, a sensing module 105 installed with each of the bodies 101, a gas sensor 106 installed with each of the bodies 101 and a holographic projection unit 107 mounted on each of the bodies 101, each of the bodies is installed with a suction pump 108 and adjacent sides of said bodies are installed with telescopically extendable pipes 109.

[0025] The system disclosed herein includes a plurality of cuboidal bodies 101 that are installed at various locations throughout the pharmaceutic industry. These cuboidal bodies 101 serve as the core units for monitoring, managing, and controlling the environmental and operational conditions within the pharmaceutical environment. Each cuboidal body 101 is installed in areas such as manufacturing floors, storage rooms, laboratories, or other high-priority zones within the pharmaceutical industry where environmental control and employee safety are of paramount importance.

[0026] Each cuboidal body 101 is wirelessly associated with a computing unit that allows for remote communication and management. The computing unit is integrated with a user-interface, which is the point of interaction for the personnel responsible for overseeing and managing the system. The user-interface is developed to be intuitive for providing user with the ability to input specific commands regarding the installation and configuration of the cuboidal bodies 101 within the industry. The user-interface acts as the control center from where a concerned person specify the type of operation being carried out in each area of the industry such as drug manufacturing, quality control, packaging, or storage. Through this interface, operators also monitor the environmental conditions to review real-time data and make necessary adjustments to the system based on the operations being conducted.

[0027] The system allows the user to define the specific functions and roles of each cuboidal body 101 based on the area in which they are installed. For example, in a drug manufacturing area, the cuboidal body 101 focus on monitoring the temperature, humidity, and air quality to ensure that the conditions align with the strict requirements for pharmaceutical production. In other areas, such as a storage room, the system emphasizes detecting any deviations in air quality or temperature that potentially compromise the integrity of the stored products. The user-interface ensures that each cuboidal body 101 is assigned appropriate functions for ensuring optimal operation across the facility.

[0028] An inbuilt microcontroller is wirelessly linked with the computing unit for processing the input commands received from the user interface and is responsible for carrying out various tasks such as interpreting instructions related to the operation, monitoring the environment, and ensuring adherence to safety guidelines. Through wireless communication, the microcontroller processes input commands in real-time, which makes the system highly efficient and responsive to changes in the environment or employee actions within the pharmaceutical facility.

[0029] The microcontroller is equipped with a database that contains detailed guidelines and regulations that employees adhere to within the facility. The system is also integrated with an artificial intelligence (AI)-based imaging unit 102 to detect and analyze employee behavior. The imaging unit 102 is capable of identifying whether the employee is disobeying established guidelines, such as improper safety practices, incorrect handling of materials, or unauthorized actions within restricted zones. When the microcontroller, through the imaging unit 102, detects any non-compliance, it triggers an alert which is wirelessly sent to the computing unit for notifying the concerned person about the employee's violation for allowing them to take immediate corrective action. This ensures that employee safety and regulatory compliance are continuously monitored for reducing the risk of accidents and ensuring that the facility adheres to strict health and safety protocols.

[0030] The imaging unit 102 is not only used for employee monitoring but also detect the height of overhead objects. In a pharmaceutical facility, there are areas with low ceilings or other obstructions that hinder the proper placement or movement of cuboidal bodies 101. The imaging unit 102 measures the distance between the cuboidal body 101 and any overhead objects to determine if it is safe to install or adjust the body 101 in a particular location. When the imaging unit 102 detects the overhead object that is too close or poses an obstruction, the microcontroller activates a telescopically operated rod 103 mounted on each cuboidal body 101. The telescopic rod 103 allows the cuboidal bodies 101 to extend and retract vertically. The extension and retraction are powered by a pneumatic unit comprising an air compressor, air cylinder, air valves, and a piston. The air compressor generates compressed air, which is directed into the air cylinder through valves. This controlled release of air forces the piston to extend or retract the rod 103 for providing the necessary vertical movement to adjust the cuboidal body’s position.

[0031] The pneumatic unit works in collaboration with the microcontroller to ensure precise control over the movement of the telescopic rod 103. When the imaging unit 102 identifies the presence of the overhead object, the microcontroller sends a signal to the pneumatic unit to extend the rod 103. This allows the cuboidal body 101 to move upward bypassing the obstruction. Once the body 101 is positioned in the desired location, a motorized clamp 104, which is equipped on each rod 103, is activated. The clamp 104 secure the cuboidal body 101 in place by gripping the overhead object and remains stable and securely positioned, even in areas where objects such as pipes, ducts, or other infrastructure are present. After the object is clamped, the rod 103 is then retracted, pulling the cuboidal body 101 back into its desired location. This allows for the installation of the cuboidal body 101 in areas near the ceiling for ensuring that it remains out of the way of everyday operations while still providing full functionality in terms of monitoring environmental conditions and employee safety.

[0032] The database that is linked directly to the microcontroller aids in ensuring that the pharmaceutical facility maintains the necessary environmental conditions specifically Air Quality Index (AQI), humidity, and temperature which are vital for the manufacturing, storage, and overall handling of pharmaceutical products. The conditions specified in the database are customized to the specific requirements of various operational areas within the pharmaceutical industry, including production areas, storage rooms, laboratories, and testing zones. The database thus functions as a repository of critical environmental data, defining the optimal parameters that are to be maintained in each zone of the facility to prevent contamination, degradation, or spoilage of pharmaceutical products.

[0033] The microcontroller has direct access to this database and enables to retrieve and process environmental data specific to each area within the facility. When the system is set up, the user defines the required AQI, temperature, and humidity for each operational area in the pharmaceutical plant. These parameters are input into the database based on regulatory guidelines, industry standards, and internal quality control procedures. For example, certain areas where sensitive pharmaceutical products are manufactured require a strict temperature range such as 18–22°C and humidity levels such as 40–60% to prevent moisture absorption or chemical instability. Similarly, areas where volatile substances are handled have specific AQI parameters to ensure proper ventilation and prevent hazardous air quality conditions.

[0034] Once the parameters are stored in the database, the microcontroller continuously accesses this data in real-time to fetch the appropriate values for AQI, humidity, and temperature for each area. This real-time querying allows the system to compare the actual environmental conditions against the predefined values stored in the database. The microcontroller constantly compares the fetched data with the real-time measurements to determine whether the environmental conditions in each area are in line with the predefined values or if any corrective actions are necessary.

[0035] Each of the cuboidal bodies 101 in the system is equipped with a sensing module 105 which is developed to detect critical parameters that directly affect the quality and safety of pharmaceutical products such as Air Quality Index (AQI), humidity, and temperature. These parameters are crucial because any deviation from the prescribed limits lead to contamination, degradation, or spoilage of sensitive pharmaceutical products which is unacceptable in the highly regulated pharmaceutical industry.

[0036] The sensing module 105 comprises of three primary types of sensors: an AQI sensor, humidity sensor, and temperature sensor. Each sensor is specifically developed to monitor the environmental conditions of the area in which the cuboidal body 101 is installed. These sensors continuously gather data on air quality, humidity, and temperature in real-time for providing a comprehensive view of the environmental conditions of each area in the pharmaceutical facility. The AQI sensor measures the air quality within the area by detecting levels of particulate matter (PM), volatile organic compounds (VOCs), and other airborne pollutants. AQI is a key parameter in pharmaceutical production areas because elevated pollutant levels lead to contamination of the air and, in turn, the products being manufactured. For example, high levels of dust, fumes, or hazardous gases compromise the sterility of the production environment, thus posing a risk to the quality and safety of the pharmaceutical products.

[0037] The humidity sensor measures the relative humidity in the area for ensuring it remains within a prescribed range. Pharmaceutical manufacturing often requires precise humidity control because excess moisture or dryness alter the chemical composition of drugs, affect their stability, or even encourage the growth of mold and bacteria. Humidity also impact the efficacy of various materials used in the production of drugs, such as active pharmaceutical ingredients (APIs) or excipients which become unstable or degrade if exposed to excessive humidity. On the other hand, the temperature sensor monitors the ambient temperature of the area. Maintaining the correct temperature is critical in pharmaceutical manufacturing as extreme heat or cold lead to the degradation of sensitive materials and active ingredients. Certain pharmaceutical products require specific temperature conditions to maintain their efficacy and safety. For example, vaccines or biologics are kept at strict temperature ranges to prevent their breakdown and ensure they retain their intended therapeutic properties.

[0038] These sensors continuously relay real-time data to the microcontroller, which is responsible for processing the data provided by the sensing module 105 and comparing it with the predefined environmental parameters stored in the database. When the microcontroller detects a mismatch or deviation between the fetched AQI, humidity, and temperature values with those stored in the database for optimal conditions and the real-time measurements gathered by the sensing module 105, it triggers an automatic corrective action. This helps to ensure that environmental conditions remain within the specified thresholds and prevents any potential risks associated with contaminated or substandard products.

[0039] For example, if the system detects that the temperature in a particular manufacturing area has risen above the specified limit such as 24°C instead of the targeted 22°C, the microcontroller immediately recognizes the discrepancy by comparing the sensor data against the stored target values. Similarly, if the AQI readings indicate that the air quality in an area has fallen below acceptable standards such as due to dust, chemical vapors, or inadequate ventilation, the microcontroller trigger corrective measures, such as activating an HVAC (Heating, Ventilation, and Air Conditioning) system or an air purifier pre-installed in each of the areas to restore the air quality to the desired level. Likewise, if the humidity in a storage area is found to be higher than the acceptable range, the microcontroller send a signal to the HVAC system to adjust the humidity levels accordingly.

[0040] The HVAC system is responsible for maintaining the temperature and humidity levels in a space by regulating the airflow, cooling, heating, and dehumidifying processes. If the temperature or humidity in a specific area is outside the acceptable range, the microcontroller instruct the HVAC system to either cool, heat, or dehumidify the air to bring the conditions back within the target range. Similarly, if the AQI sensor detects poor air quality due to the presence of particulate matter or toxic gases, the microcontroller sends a signal to the air purifier unit. The air purifier is responsible for removing pollutants from the air, such as dust, fumes, or volatile organic compounds (VOCs), which are harmful to both the environment and the pharmaceutical products being produced. The air purifier uses filters to clean the air and restore it to the required AQI levels for ensuring that the air in the facility is safe and free from contaminants. By continuously monitoring and adjusting the environment, this system reduces the risk of human error and allows for efficient, automated operation, making this ideal for pharmaceutical production facilities that operate under strict quality control and regulatory requirements.

[0041] Each cuboidal body 101 in the system is equipped with a gas sensor 106 developed to detect the presence of toxic gases within the pharmaceutical production areas. This sensor is particularly important in environments where the manufacturing process involves the use of potentially hazardous chemicals or volatile substances that emit toxic gases. These gases pose severe health risks to employees and also compromise the quality and safety of the pharmaceutical products being produced.

[0042] The gas sensor 106 works by continuously monitoring the air for the presence of specific toxic gases. These gases include, but are not limited to, volatile organic compounds (VOCs), ammonia, carbon monoxide, hydrogen sulfide, or other hazardous substances that are produced during the pharmaceutical production process. The gas sensor 106 is highly sensitive and capable of detecting even trace amounts of toxic gases in the air. When it identifies a concentration of gas that exceeds the safety threshold, it triggers an alert within the system.

[0043] Once the gas sensor 106 detects the presence of a harmful gas, it sends a signal to the microcontroller for processing this data and determining the appropriate course of action based on the level and type of toxic gas detected. The system is pre-fed to evaluate the severity of the gas release, considering factors such as the concentration of the gas, the specific type of gas, and the safety guidelines established for the pharmaceutical facility. If the microcontroller determines that the gas concentration is above a critical threshold, the microcontroller take immediate corrective actions to mitigate the risk to both personnel and the environment.

[0044] The microcontroller then triggers an alert through the user interface for notifying the concerned personnel about the detected gas release and the level of potential hazard in the area. This alert is sent in real-time to supervisors for allowing them to respond quickly to prevent any health issues or damage to the production process. In addition to the alert, the microcontroller activates a holographic projection unit 107 mounted on each of the cuboidal bodies 101 to provides a visual and highly interactive way to communicate critical information to the personnel within the affected area. When the gas sensor 106 detects a hazardous gas release, the holographic unit projects a real-time hologram that displays detailed, step-by-step instructions on how to address the situation and reduce the release of toxic gas.

[0045] The hologram includes a variety of safety measures, such as:

• Evacuation protocols: The hologram provide clear instructions on how to safely evacuate the area if the gas concentration is dangerous to human health and display exit routes, assembly points, and other safety information crucial to protecting employees.

• Protective gear instructions: If the gas release poses a lesser threat but still requires precautionary measures, the hologram instruct personnel to wear appropriate personal protective equipment (PPE), such as gas masks, gloves, or protective suits, to minimize exposure to the toxic gases.

• Emergency response steps: The hologram guide employees on how to initiate emergency response measures such as turning off equipment that cause the gas release and activating ventilations or using gas scrubbers and filters to mitigate the concentration of the harmful gas.

• Dealing with specific gas types: Depending on the detected gas, the hologram provides specific information about that particular substance, such as its chemical properties, symptoms of exposure, and recommended measures to neutralize or contain the gas. This help employee in better understanding the nature of the hazard and take more informed actions.

• Instructions to activate ventilation or gas containment systems: The hologram also provide visual guides to activate specific ventilation, such as exhaust fans or air scrubbers that help remove the toxic gas from the environment, ensuring that the area is safe for work again as quickly as possible.

[0046] This visual, real-time communication approach significantly enhances safety within the pharmaceutical facility by providing employees with immediate and clear instructions during potentially dangerous situations. The holographic projection unit 107 ensures that personnel take appropriate action without confusion or delay, thus reducing the likelihood of human error and minimizing health risks.

[0047] The gas sensor 106 and holographic projection unit 107 work in conjunction to create a comprehensive safety network within the pharmaceutical facility. While the gas sensor 106 is responsible for detecting the presence of toxic gases and triggering alerts, the holographic projection unit 107 serves as an immediate and effective means of communicating vital information to personnel in a highly visual and interactive format.

[0048] Herein, in case the microcontroller via imaging unit 102 monitor any instances where the employee is disobeying predefined guidelines, such as not wearing the proper protective gear, engaging in unsafe behavior, or violating other operational protocols. These guidelines are stored in the database, and the imaging unit 102 continuously compares the behavior of employees with these guidelines. If the imaging unit 102 detects a violation, the microcontroller triggers an alert. This alert is wirelessly transmitted to the computing unit, which notifies the concerned personnel and this real-time notification ensures that any non-compliance is immediately addressed for preventing potential safety risks or operational disruptions.

[0049] Each cuboidal body 101 is equipped with a suction pump 108 that is automatically activated by the microcontroller when the gas sensor 106 detects the presence of toxic or hazardous gases within the area. The gas sensor continuously monitors the air quality and detect even minute concentrations of potentially harmful gases that expose danger both the health of the workers and the quality of the pharmaceutical products being manufactured. Upon detection of these toxic gases, the microcontroller receives the signal from the gas sensor and triggers the suction pump 108 to begin the process of removing the hazardous substances from the air. This immediate response minimizes the risk of exposure to toxic gases and ensures the environment remains safe for both employees and the integrity of the manufacturing process.

[0050] The suction pump 108 is connected to a set of telescopically extendable pipes 109 installed on the adjacent sides of each cuboidal body. These pipes 109 are developed to extend outward and connect with outlet vents located throughout the pharmaceutical area. The telescopic nature of the pipes 109 allows for flexibility and reach, enabling them to connect with the vents regardless of the layout or size of the area. When activated, the telescopic pipes 109 extend and form a secure connection with these vents, thus creating a direct path for the expulsion of toxic gases. This ensures that any detected toxic gases are rapidly and effectively removed from the workspace, preventing them from accumulating and creating hazardous conditions. Once the gases are expelled through the outlet vents, they are either released into a safe containment or vented outside the facility, depending on the design of the building. This setup ensures that toxic gases do not linger in the working environment in view of protecting the health of the personnel and maintaining the safety and cleanliness of the pharmaceutical production area.

[0051] Lastly, a battery (not shown in figure) is associated with the system to supply power to electrically powered components which are employed herein. The battery is comprised of a pair of electrodes named as a cathode and an anode. The battery uses a chemical reaction of oxidation/reduction to do work on charge and produce a voltage between their anode and cathode and thus produces electrical energy that is used to do work in the system.

[0052] The present invention works best in the following manner, where the plurality of cuboidal bodies 101 is installed in different areas of the pharmaceutical industry as disclosed in the proposed invention. Each cuboidal body 101 equipped with the computing unit via wireless communication. The concerned person uses the user-interface of the computing unit to input commands specifying the areas and operations to be monitored. The microcontroller processes these commands and continuously monitors environmental conditions through sensors that measure AQI, humidity, and temperature. If any deviation from the required parameters is detected, the microcontroller sends signal to the HVAC system and air purifiers to adjust the environment and maintain optimal conditions. The system incorporates the imaging unit 102 that detect employee behavior, ensuring compliance with safety guidelines. If employee is found violating the guidelines, the microcontroller sends alert to the computing unit for notifying the concerned person. The system also detects overhead objects using AI-based imaging and adjusts the cuboidal bodies 101 positioning by extending the telescopic rod 103 powered by the pneumatic unit. The rod 103 clamps the object and retracts to position the cuboidal body 101 closer to the ceiling. In case of toxic gas release, the gas sensor 106 activates the holographic projection unit 107 that displays emergency guidelines for handling the situation.

[0053] Although the field of the invention has been described herein with limited reference to specific embodiments, this description is not meant to be construed in a limiting sense. Various modifications of the disclosed embodiments, as well as alternate embodiments of the invention, will become apparent to persons skilled in the art upon reference to the description of the invention.
, Claims:1) A monitoring and management system for pharmaceutic industry, comprising:

i) plurality of cuboidal bodies 101, associated with said system, developed be installed at different areas of a pharmaceutical industry, wherein a user-interface inbuilt in a computing unit is wirelessly associated with said system for enabling a concerned person to give input commands for installation of said bodies 101 and specifying type of operation being carried out in each of said area;
ii) a microcontroller wirelessly linked with said computing unit that processes said input commands and activates an artificial intelligence-based imaging unit 102 paired with a processor mounted on each of said bodies 101 for detecting height of an overhead object over said bodies 101, wherein said microcontroller actuates a telescopically operated rod 103 installed on each of said bodies 101 to extend, followed by actuation of a motorized clamp 104 equipped with each of said rod 103 to clamp said object, followed by re-retraction of said rod 103 to allow installation of said bodies 101 near ceiling portion of said areas;
iii) a database linked with said microcontroller that is stored with details regarding AQI (Air Quality Index), humidity, and temperature to be maintained for each of said operations, wherein said microcontroller accesses said database for fetching said AQI, humidity, and temperature to be maintained in each of said areas;
iv) a sensing module 105 installed with each of said bodies 101 for detecting said AQI, humidity, and temperature in said areas, wherein in case said detected AQI, humidity, and temperature mismatches with said fetched AQI, humidity, and temperature, said microcontroller sends a signal to a processor of HVAC (Heating Ventilation and Air Conditioning) system and an air purifier unit pre-installed in each of said areas for maintaining said fetched AQI, humidity, and temperature of said area to prevent contamination/degradation of pharmaceutical products being manufactured in said industry; and
v) a gas sensor 106 installed with each of said bodies 101 for detecting release of any toxic gas in said area, wherein said microcontroller activates a holographic projection unit 107 mounted on each of said bodies 101 to project hologram regarding various steps to be taken to prevent health issues and cut-down the release of toxic gas.

2) The system as claimed in claim 1, wherein said sensing module 105 includes an AQI sensor, humidity sensor, and temperature sensor.

3) The system as claimed in claim 1, wherein in case said microcontroller via said imaging unit 102 detects any of employee in said areas to be disobeying guidelines provided to said employees, as stored in said database, said microcontroller sends an alert on said computing unit for notifying said concerned person regarding said employee.

4) The system as claimed in claim 1 and 3, wherein said microcontroller is wirelessly linked with said processor and computing unit via a communication module which includes, but not limited to Wi-Fi (Wireless Fidelity) module, Bluetooth module, GSM (Global System for Mobile Communication) module.

5) The system as claimed in claim 1, wherein said telescopically operated rod 103 is powered by a pneumatic unit that includes an air compressor, air cylinder, air valves and piston which works in collaboration to aid in extension and retraction of said rod 103.

6) The system as claimed in claim 1, wherein each of said bodies is installed with a suction pump 108 that is activated by said microcontroller in case release of toxic gasses is detected via said gas sensor, wherein adjacent sides of said are installed with telescopically extendable pipes 109 that extend and connect with outlet vents of said area to expel said gasses and prevent the people working in said area.

7) The system as claimed in claim 1, wherein a battery is associated with said system for supplying power to electrical and electronically operated components associated with said system.